Volume 21, Number 7—July 2015
Dispatch
Evaluation of Patients under Investigation for MERS-CoV Infection, United States, January 2013–October 2014
Eileen Schneider
, Christina Chommanard, Jessica M. Rudd, Brett L. Whitaker, Luis Lowe, and Susan I. Gerber
, Christina Chommanard, Jessica M. Rudd, Brett L. Whitaker, Luis Lowe, and Susan I. Gerber
Table 2
Countries from which 381 PUIs for MERS-CoV infection had traveled within 14 days of symptom onset, United States January 1, 2013–October 31, 2014*
| Country | No. (%) |
|---|---|
| Saudi Arabia | 189 (49.6) |
| United Arab Emirates | 60 (15.7) |
| Israel | 45 (11.8) |
| Jordan | 34 (8.9) |
| Qatar | 27 (7.1) |
| Kuwait | 22 (5.8) |
| Egypt | 12 (3.1) |
| Bahrain | 10 (2.6) |
| Oman | 9 (2.4) |
| Iran | 8 (2.1) |
| Iraq | 8 (2.1) |
| Lebanon | 8 (2.1) |
| Turkey | 8 (2.1) |
| Pakistan | 6 (1.6) |
| Palestinian Territories | 6 (1.6) |
| Yemen | 6 (1.6) |
| Other† | 13 (3.4) |
*Patients may have been in >1 country. PUI, patient under investigation.
†Azerbaijan (1); Afghanistan (2); Bangladesh (1); Greece (1); India (2); Indonesia (2); Kenya (1); Morocco (1); Somalia (1); Syria (1).
Page created: June 15, 2015
Page updated: June 15, 2015
Page reviewed: June 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.